RRE Ventures

RRE Ventures is a New York-based early-stage firm founded in 1994 by Stuart Ellman and Jim Robinson IV, with a portfolio that has included BuzzFeed (early), Datadog (early), Venmo, Hashicorp, OnDeck, and a long bench of enterprise and consumer companies, and a current practice that spans AI, healthcare, climate, fintech, robotics, space, and what the firm calls “silvercare.” The firm is a multi-thesis early-stage shop, not a healthcare specialist, but RRE has been a credible healthcare-AI investor over the years, with bets including Anomaly (AI-driven healthcare payments accuracy and predictive editing of claims) and other AI-and-healthcare crossovers. The healthcare practice is intentional but selective, and the wedge RRE looks for is technical: AI applied to a hard healthcare problem (payments, claims, clinical documentation, imaging, diagnostics), with a clear data moat and an enterprise or payer customer profile. Stage focus is seed and Series A, with check sizes typically in the two-to-eight-million range at first entry and reserves to follow through Series B; RRE is not a multi-stage growth firm and will not lead later rounds, although the firm has continued to support breakout companies through follow-on participation. Geography is New York-centric and US-focused, with a strong East Coast network and selective West Coast and Israeli activity. Founders who should approach RRE are early-stage technical founders building AI-native software with a healthcare or fintech application, founders who appreciate a New York-based partner who is well-connected to East Coast enterprise buyers (banks, insurers, health systems, pharma) and to the Northeast university research bench (Columbia, NYU, Cornell, MIT), and founders who want a partnership that has been investing through multiple cycles and has a long memory of how categories evolve. Founders who should look elsewhere are clinical-stage biotech, devices, services-heavy care delivery, and consumer DTC health without a software core; these are not RRE’s category. The entry path that works best is a warm intro through a New York-based portfolio CEO, through the East Coast technical-talent network, or through the firm’s reasonably active scout and operator-in-residence programs. When you pitch, lead with the technical wedge and the data moat; RRE partners are engineering-friendly and will engage on technical detail in early meetings. Caveats: RRE is a medium-sized, partner-driven firm rather than a platform-style firm, so the value-add is the partner’s time, network, and operating advice rather than back-office services; valuations are market for early stage; governance includes board seats and active partner involvement; and the firm’s healthcare-specific bench is less dense than at firms like General Catalyst or Bessemer, so healthcare founders should reference-call on healthcare-specific partner experience before signing.